ACR: Contraception Choice May Affect RA-Related Autoantibodies

This article originally appeared here.
Share this content:
ACR: Contraception Choice May Affect RA-Related Autoantibodies
ACR: Contraception Choice May Affect RA-Related Autoantibodies

(HealthDay News) -- For women at increased risk of rheumatoid arthritis (RA), choice of contraceptive may affect serum autoantibodies to citrullinated protein antigens (ACPA) positivity, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 14 to 19 in Boston.

The authors note that the preclinical phase of RA development is characterized by elevations of serum RA-related autoantibodies, including ACPA. With this in mind, Sonia Khatter, from the University of Colorado School of Medicine in Aurora, and colleagues evaluated 336 first-degree relatives (FDR) of probands with RA. At their baseline visit, the patients had serum enzyme-linked immunosorbent assay testing for ACPA and a contraceptive and pregnancy history taken. Only one subject was selected per family and consequently the final analysis included 297 FDRs.

The researchers found that after adjustment for age, race, and smoking, prior use of the oral contraceptive pill correlated with reduced risk of serum ACPA positivity (odds ratio, 0.34). Women who had a history of intrauterine device use had increased risk for ACPA positivity (odds ratio, 2.68, after adjustment for age, race, and smoking). There were no significant correlations between ACPA positivity and pregnancy or breastfeeding.

"We think these findings are very exciting and will lead to future studies that improve our understanding of RA development in women," a coauthor said in a statement.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »